Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 37,650
Change Today -362.00 / -0.95%
Volume 1.1M
APN On Other Exchanges
Symbol
Exchange
Johannesburg
OTC US
OTC US
Frankfurt
As of 11:00 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stephen Bradley Saad BCom, CA(SA)

Group Chief Executive Officer and Executive Director, Aspen Pharmacare Holdings Limited
AgeTotal Calculated CompensationThis person is connected to 11 board members in 2 different organizations across 2 different industries.

See Board Relationships
50R15,300,000
As of Fiscal Year 2014

Background*

Mr. Stephen Bradley Saad, BCom, CA, serves as the Group Chief Executive Officer of Aspen Pharmacare Holdings Limited since 2000. Mr. Saad served as a Joint Chief Executive of Aspen Pharmacare Holdings Ltd. He has been an Executive Director of Aspen Pharmacare Holdings Limited since January 1999. Mr. Saad is a CA from South Africa Institute of CAs and holds a B.Com through the University of Natal in South Africa.

Corporate Headquarters*

Aspen Park
Durban, KwaZulu-Natal 4019

South Africa

Phone: 27 31 580 8600
Fax: 27 31 580 8647

Board Members Memberships*

Director
1999-Present
Group Chief Executive Officer and Executive Director

Education*

Bachelor's Degree
The University of KwaZulu-Natal
Associate's Degree
South African Institute of Chartered Accountants

Other Affiliations*

Annual Compensation*

SalaryR5,800,000
BonusR6,500,000
Total Annual CompensationR12,300,000

Stock Options*

Restricted Stock AwardsR2,300,000
All Other CompensationR700,000

Total Compensation*

Total Annual Cash CompensationR13,000,000
Total Short Term CompensationR12,300,000
Other Long Term CompensationR3,000,000
Total Calculated CompensationR15,300,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
APN:SJ 37,650.00 -362.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Joseph Jimenez MBAChief Executive Officer
Novartis AG
SFr.6.1M
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
$1.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASPEN PHARMACARE HOLDINGS LT, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.